α-Glucosidase inhibitors as potential broad based anti-viral agents - Wikidata - wikimedia - TriplyDB

α-Glucosidase inhibitors as potential broad based anti-viral agents

α-Glucosidase inhibitors as potential broad based anti-viral agents

http://www.wikidata.org/entity/Q29036682

about

Alpha-glucosidase inhibitors reduce dengue virus production by affecting the initial steps of virion morphogenesis in the endoplasmic reticulum Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus Assembly and Maturation of the Flavivirus Kunjin Virus Appear To Occur in the Rough Endoplasmic Reticulum and along the Secretory Pathway, Respectively Antiviral effects of an iminosugar derivative on flavivirus infections Detection of Inhibition of Bovine Viral Diarrhea Virus by Aromatic Cationic Molecules Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents Replication-Competent Recombinant Vesicular Stomatitis Virus Encoding Hepatitis C Virus Envelope Proteins Specificity of Processing -Glucosidase I Is Guided by the Substrate Conformation: CRYSTALLOGRAPHIC AND IN SILICO STUDIES The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo Glycosidase inhibitors: a patent review (2008-2013).Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus.Mass spectrometric characterization of proteins from the SARS virus: a preliminary report.Transcriptome analysis of the whitefly, Bemisia tabaci MEAM1 during feeding on tomato infected with the crinivirus, Tomato chlorosis virus, identifies a temporal shift in gene expression and differential regulation of novel orphan genes.Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.Alkaloidal sugar mimetics: biological activities and therapeutic applications.Identification of the genes involved in 1-deoxynojirimycin synthesis in Bacillus subtilis MORI 3K-85.Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme.Folding of viral envelope glycoproteins in the endoplasmic reticulum.Strategies to eliminate HBV infection.Evolving therapies for the treatment of chronic hepatitis B virus infection.Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs.Hepatitis C virus therapies: current treatments, targets and future perspectives.Effects of interferon, ribavirin, and iminosugar derivatives on cells persistently infected with noncytopathic bovine viral diarrhea virus.Possible FDA-approved drugs to treat Ebola virus infection A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)Characterization of different crystal forms of the alpha-glucosidase MalA from Sulfolobus solfataricus RNA Interference based Approach to Down Regulate Osmoregulators of Whitefly (Bemisia tabaci): Potential Technology for the Control of Whitefly.Versatility of the endoplasmic reticulum protein folding factory.Monitoring of S protein maturation in the endoplasmic reticulum by calnexin is important for the infectivity of severe acute respiratory syndrome coronavirus.Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.Glycosidase inhibition: assessing mimicry of the transition state.Alternative approaches to antiviral treatments: focusing on glycosylation as a target for antiviral therapy.Bitter-sweet symphony: glycan-lectin interactions in virus biology.Computer-aided molecular design of novel glucosidase inhibitors for AIDS treatment.Emerging structural insights into glycoprotein quality control coupled with N-glycan processing in the endoplasmic reticulum.Treatment of hepatitis B virus: an update.Investigational drugs in early development for treating dengue infection.alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.The use of calnexin and calreticulin by cellular and viral glycoproteins.

P2860

Q27469618-D1EB35E3-4415-46C5-AC4B-8339054C8EAD Q27469853-F6413CDB-3D0D-4005-A95E-AF77D313945C Q27469877-4E8DDBBB-2717-4C56-BAAA-A973300A0212 Q27472863-CA4A02F1-E6B2-422D-8304-BEDE0CFD8783 Q27477550-D0A66281-7D18-49A3-8A45-0CEC1B6BCDA9 Q27478192-083F798E-2796-4334-9C09-98EE70072613 Q27481021-C8AF19E3-0418-4412-A0C9-A97ABA269430 Q27677099-CB5662B7-5EF7-42DA-A673-1070D7D21A73 Q28142779-4A273B8E-31EB-4AA7-AEE3-FFE5605B1099 Q30363930-DEFC5C0D-B240-45B8-BAE8-0BFEBF1B0718 Q30671216-C4B8BA3B-FFB3-424D-A6D5-31C5C6289D0C Q30939828-07CFF94A-1872-4D80-8BFB-6F7A82686199 Q33660421-6786D560-FA91-487A-9420-E3B189CDEA8D Q33756008-5B180859-202A-4821-B356-1A544C097B76 Q33842989-25F778A9-E617-4690-BC0D-49CCDA3E3A4A Q33918682-27F688D9-3A38-4A18-A440-0A323B0C6F7D Q33946780-F06345D2-0B8D-4200-B2CC-579D744DEFA6 Q34045589-A13BDD96-57A4-479A-85FE-D8B8E43E6371 Q34156701-1F1E9CBE-0777-49C1-8D8B-9BB3C639BA8A Q34308129-7BDCCE83-DE55-451E-BCD9-EE4775371F54 Q34519117-600C9797-DA9E-4295-A720-05F6EEFB3350 Q34644755-3D11924E-2547-4754-A2A7-69438AAC2CF8 Q35147050-14144512-6D79-4503-BCA7-86D7FA85CE10 Q35548601-575B39CB-D5AA-4A26-997A-EA3C619FFBB1 Q35609603-CBC6B1AD-3D5F-4EAF-9DF9-439771DBD4DE Q35676012-4C95A77C-104A-4645-AD27-597E491AEEC4 Q35994962-4283BF6C-AF63-486F-A2E3-58640C8DD686 Q35997068-30481CC6-B8F4-432F-ABCA-6B689D08B1D7 Q36242585-2390D2FD-6698-4524-AE84-A51DB964EB8B Q36363294-334734E3-7A35-460E-93AE-8A59B1CC81DB Q37340035-622E06A1-88A6-4C15-B0E2-A1A47A54F9DB Q37672358-F08D6929-71CA-4655-8441-2C118ABB849F Q37774669-5426C8A8-AB1A-4BE5-B2F0-9B5B3F7B0FE9 Q38159719-9A4CA22F-41D9-44BD-AE65-17191417F81F Q38339745-C6D42DAC-E465-4F8A-B261-154B18805B50 Q38342650-D1583159-626C-4C9B-9E5E-94CDF2EE9C7E Q38794446-3BFADBA7-207A-4748-A865-B45DCC48BF00 Q38870485-A02B30C9-22A3-4D5C-BFEA-D3683D1E9948 Q40193811-959F8D34-2B1D-4888-8550-FD6DFE3AE475 Q40410568-5F9AEF3F-1B2C-4962-A281-B4447341067F

P2860

α-Glucosidase inhibitors as potential broad based anti-viral agents

http://www.wikidata.org/entity/Q29036682

description

1998 nî lūn-bûn

@nan

1998 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

α-Glucosidase inhibitors as potential broad based anti-viral agents

@ast

α-Glucosidase inhibitors as potential broad based anti-viral agents

@en

type

label

α-Glucosidase inhibitors as potential broad based anti-viral agents

@ast

α-Glucosidase inhibitors as potential broad based anti-viral agents

@en

prefLabel

α-Glucosidase inhibitors as potential broad based anti-viral agents

@ast

α-Glucosidase inhibitors as potential broad based anti-viral agents

@en

P1433

Q29036682-6A451056-9C63-45B4-9E0D-0B0685A3E5F5

P1476

Q29036682-E60E33ED-CC80-4B07-9AD7-24A470E2859D

P2093

Q29036682-0ADCC2E5-BF22-4706-AD27-03A89C121F3D

Q29036682-4646C66C-C517-43CF-9208-A53F944F9055

Q29036682-5E589707-5F9C-4ABB-BB4C-801C4CB3233B

Q29036682-84E5F997-5A02-4DEF-9B54-AE3B3D2DB4AA

Q29036682-E37C4AAC-F70C-4FEC-B2B6-22D6C7506D35

P2860

Q29036682-12F484E8-71E9-477E-B1F8-C80208E0BBBB

Q29036682-2667B113-9BB4-487E-BD6F-32AF732B385B

Q29036682-2A27FD30-326F-43CB-BC07-6F729EF3A73B

Q29036682-2D2D3A1B-3516-4B2E-9DE5-9F782B3898B3

Q29036682-4D5EB9C3-254C-4B50-B4CA-A12FA8746CEE

Q29036682-6783D3CC-A7E9-489C-88AE-D726D146481A

Q29036682-8DF30322-4AEE-438E-B76A-50D66993344E

Q29036682-9687A61B-7D76-4F0A-B59F-A9B125455DD7

Q29036682-97388032-B014-437E-B521-9B347C7ACC51

Q29036682-9CA3600C-EE57-4D85-8800-F065DDBDE559

P304

Q29036682-57791FEC-1276-4D11-8985-290BDE064FF9

P31

Q29036682-F5316811-F3BE-46A8-98CD-3F057187D94B

P3181

Q29036682-6BA3D18D-6F29-44F9-91CE-E4343A54E611

P356

Q29036682-CEC135F4-D374-45CD-9022-332AE7841D5F

P407

Q29036682-AA2FF991-6DBC-4431-AFD1-E7440AC50313

P433

Q29036682-8F624EB9-A367-42A9-AD60-8DFF13DCC1A7

P478

Q29036682-5514A64B-F06E-423D-9E18-E2BA370E1C87

P577

Q29036682-C4058F77-521F-465F-B36A-F004A2165AE4

P698

Q29036682-A79D85C7-2690-4044-BB57-92D99AB9D219

P3181

P356

S0014-5793(98)00525-0

P1433

P1476

α-Glucosidase inhibitors as potential broad based anti-viral agents

@en

P2093

Anand Mehta

http://www.w3.org/2001/XMLSchema#string

Nicole Zitzmann

http://www.w3.org/2001/XMLSchema#string

Pauline M Rudd

http://www.w3.org/2001/XMLSchema#string

Raymond A Dwek

http://www.w3.org/2001/XMLSchema#string

Timothy M Block

http://www.w3.org/2001/XMLSchema#string

P2860

Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control

Aminosugar derivatives as potential anti-human immunodeficiency virus agents.

How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum.

Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin

Molecular genetics of pestiviruses.

Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion

Aberrant trafficking of hepatitis B virus glycoproteins in cells in which N-glycan processing is inhibited

Conformation-independent binding of monoglucosylated ribonuclease B to calnexin.

Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

P304

17-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2146532

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0014-5793(98)00525-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

430

http://www.w3.org/2001/XMLSchema#string

P577

1998-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9678587

http://www.w3.org/2001/XMLSchema#string